Steroid nasal sprays reduce COVID-related poor outcomes, study suggests
Fox News
Regular use of steroid nasal sprays afforded COVID-19 patients protection against virus-related hospitalization, ICU admission and death, the Cleveland Clinic announced Tuesday.
Researchers excluded patients who received INCS prescriptions prior to 2018, as well as pregnant women, those with missing hospitalization data and others.
Patients receiving the spray before COVID-19 illness faced a 22% lower likelihood of virus-related hospitalization, 23% lower odds of ICU admission and 24% reduced risk of COVID-related hospital death, versus patients not taking a steroid nasal spray, according to a release from the Cleveland Clinic.
Clonazepam, popular anxiety-reducing drug, recalled nationwide for ‘possibly life-threatening’ error
The anxiety-reducing drug, Clonazepam, has been recalled after a potentially "life-threatening" label mix-up, the FDA said in the recall.